Pricing

ALTIUM CAPITAL MANAGEMENT LLC

2 followers ยท 1 like
NEW YORK NY
13F Summary
Altium Capital Management is based out of New York. Their last reported 13F filing for Q1 2025 included $41,500,012 in managed 13F securities and a top 10 holdings concentration of 86.71%. Altium Capital Management's largest holding is Zevra Therapeutics Inc with shares held of 1,287,333. Whalewisdom has at least 21 13F filings, and 175 13G filings

2025-03-31

Top Buys (13F)

2025-03-31

Top Sells (13F)

2025-03-31

13F Holdings Summary

Name $ Change
ZVRA Zevra Therapeutics I 23.23%
ALNY Alnylam Pharmaceutic(PUT) 16.27%
EOLS Evolus Inc 8.59%
XTNT XTANT MED HLDGS INC 8.21%
AVDL Avadel Pharmaceutica 7.91%

2025-03-31

13F Activity

Market Value $41.5m, Prior: $353m
Inflows (Outflows) as % of Total MV (-127.6981)%
New Purchases 5 stocks
Added To 0 stocks
Sold out of 48 stocks
Reduced holdings in 18 stocks
Top 10 Holdings % 86.71%
Turnover %[1] 73.61%
Turnover Alt %[2] 17.54%
Time Held Top 20 0.7 quarters
Time Held Top 10 0.7 quarters
Time Held All 2.96 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2025-03-31

13F Sector Allocation Over Time

limited to past 4 quarters. Subscribe to see all available data

2025-03-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2025-03-31

Portfolio Performance